CUP AND HANDLE FORMING NEW PT 6.50+Price above 200 EMA. Bounced off-diagonal support. Bounced off 50% retracement. RSI Oversold. Confirmed trend reversal.
−4.08USD
−87.37 MUSD
20.48 M
About Verastem, Inc.
Sector
Industry
CEO
Daniel W. Paterson
Website
Headquarters
Needham
Employees (FY)
73
Founded
2010
ISIN
US92337C2035
FIGI
BBG001J2LSK5
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
OVERSOLD, BOUNCED OFF TREND LINE, TESTED 50% RETRACEMENTOVERSOLD, BOUNCED OFF TREND LINE, TESTED 50% RETRACEMENT. Great price to buy in my opinion.
FDA gave breakthrough designation..Verastem announced it received FDA Breakthrough Therapy designation for VS-6766 with defactinib in recurrent low-grade serous ovarian cancer.
If the flag holds, it looks like it could hit around $4.60. Considering adding to my position today. But probably will just hold with what I have.
VSTM Verastem Inc. - Is VSTM forming a W on a weekly chart?Is VSTM forming a W on a weekly chart?
Decide for yourself.
Resistance @2,7 @4,7 @10,30 and the sky is above 19 $
Good luck and happy trading everyone!
VSTM Verastem - nice W forming - is this going to the sky soon? VSTM - nice W forming - is this going to the sky @ 19 $ and above ?
Nice volume and start of steady uptrend.
GOOD LUCK and enjoy investing
Target in sight. $vstmLooks to me like an ascending triangle breakout. Unfortunately, the volume is fairly week, but we'll see where it takes us.
I plan on taking profits in the yellow area. I might run a trailing stop loss when it enters that area and just let it run.
$vstm
$VSTM Verastem, Inc., Potential 20% UpsideVerastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA™ (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibit
$VSTM Bullish opportunity targeting double current price 1.48Bullish setup formed by 3 red daily candles closing at same price . this pattern can lead to significant price change and RSI signal positively .. bullish long more likely with stoploss at 1.25 (not far away) risk reward (-20% vs +100%). to be watched closely!!
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VSTM is 10.23 USD — it has decreased by 5.63% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Verastem, Inc. stocks are traded under the ticker VSTM.
Verastem, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
VSTM stock is 8.15% volatile and has beta coefficient of 1.66. Check out the list of the most volatile stocks — is Verastem, Inc. there?
One year price forecast for Verastem, Inc. has a max estimate of 36.00 USD and a min estimate of 17.50 USD.
VSTM earnings for the last quarter are −0.75 USD whereas the estimation was −0.84 USD which accounts for 11.02% surprise. Estimated earnings for the next quarter are −0.61 USD. See more details about Verastem, Inc. earnings.
Verastem, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 33.33 K USD. In the next quarter revenue is expected to reach 7.12 M USD.
Yes, you can track Verastem, Inc. financials in yearly and quarterly reports right on TradingView.
VSTM stock has fallen by 9.23% compared to the previous week, the month change is a 2.20% fall, over the last year Verastem, Inc. has showed a 118.50% increase.
VSTM net income for the last quarter is −27.37 M USD, while the quarter before that showed −20.00 M USD of net income which accounts for −36.81% change. Track more Verastem, Inc. financial stats to get the full picture.
Today Verastem, Inc. has the market capitalization of 274.20 M, it has increased by 2.95% over the last week.
No, VSTM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VSTM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Verastem, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 73.00 employees. See our rating of the largest employees — is Verastem, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Verastem, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Verastem, Inc. stock shows the sell signal. See more of Verastem, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Verastem, Inc. future price: according to them, VSTM price has a max estimate of 36.00 USD and a min estimate of 17.50 USD. Read a more detailed Verastem, Inc. forecast: see what analysts think of Verastem, Inc. and suggest that you do with its stocks.